Gynecologic surgeries and risk of ovarian cancer in women with BRCA1 and BRCA2 Ashkenazi founder mutations: an Israeli population-based case-control study

By Leiserowitz Gary  

The Women's Oncology Review, Vol. 4, Iss. 1, 2004-01 ,pp. : 35-36

Informa Healthcare

Access to resources Recommend Favorite

Occurrence of both breast and ovarian cancer in a woman is a marker for the BRCA gene mutations: a population-based study from Western Sweden

By Einbeigi Zakaria   Bergman Annika   Meis-Kindblom Jeanne   Flodin Anna   Bjursell Cecilia   Martinsson Tommy   Kindblom Lars-Gunnar   Wahlström Jan   Wallgren Arne   Nordling Margareta   Karlsson Per  

Familial Cancer, Vol. 6, Iss. 1, 2007-03 ,pp. : 35-41

Springer Publishing Company

Access to resources Recommend Favorite

BRCA1 Germline Mutations and Polymorphisms in a Clinic-Based Series of Ovarian Cancer Cases: A Gynecologic Oncology Group Study

By Smith S.A.   Richards W.E.   Caito K.   Hanjani P.   Markman M.   DeGeest K.   Gallion H.H.  

Gynecologic Oncology, Vol. 83, Iss. 3, 2001-12 ,pp. : 586-592

Elsevier

Access to resources Recommend Favorite

Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2

By Neibergs Holly  

The Women's Oncology Review, Vol. 4, Iss. 1, 2004-01 ,pp. : 59-60

Informa Healthcare

Access to resources Recommend Favorite

Germline Mutations of theBRCA1andBRCA2Genes in a Breast and Ovarian Cancer Patient

By Randall T.C.   Bell K.A.   Rebane B.A.   Rubin S.C.   Boyd J.  

Gynecologic Oncology, Vol. 70, Iss. 3, 1998-09 ,pp. : 432-434

Elsevier

Access to resources Recommend Favorite